Back
Akari Therapeutics PLC Stock Price Chart
Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
AKTX
Akari Therapeutics PLC
Last Price:
$1.17
Seasonality Move:
-6.68%
7 Day Trial
ALL ACCESS PASS
$
7
He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and AKTX is experiencing slight buying pressure.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.14 | Sell |
| 20-day SMA: | 1.25 | Sell |
| 50-day SMA: | 1.11 | Buy |
| 200-day SMA: | 2.15 | Sell |
| 8-day EMA: | 1.14 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.17 | Sell |
| 200-day EMA: | 1.82 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.03 | Sell |
| Chaikin Money Flow: | 1967 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.36) | Sell |
| Bollinger Bands (100): | (0.96 - 1.36) | Sell |
Akari Therapeutics PLC Technical Analysis
| Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.11 while AKTX 8-day simple moving average is 1.14, which is a Sell signal.
-
The stock price of AKTX is 1.11 while Akari Therapeutics PLC 20-day SMA is 1.25, which makes it a Sell.
-
Akari Therapeutics PLC 50-day simple moving average is 1.11 while AKTX share price is 1.11, making it a Buy technically.
-
AKTX stock price is 1.11 and Akari Therapeutics PLC 200-day simple moving average is 2.15, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
23
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a SellThe current Akari Therapeutics PLC [AKTX] share price is $1.11. The Score for AKTX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
27.6M
Price in USD:
1.11
Share Volume:
5K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.85
Sell
23
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 1.11 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.11 while AKTX 8-day exponential moving average is 1.14, which is a Sell signal.
-
The stock price of AKTX is 1.11 while Akari Therapeutics PLC 20-day EMA is 1.16, which makes it a Sell.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.17 while AKTX share price is 1.11, making it a Sell technically.
-
AKTX stock price is 1.11 and Akari Therapeutics PLC 200-day simple moving average is 1.82, creating a Sell signal.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Akari Therapeutics PLC is a Sell
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 47.03, which suggest Akari Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (1.02 - 1.36), which suggest Akari Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (0.96 - 1.36), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.